Tomesha Campbell joined F-Prime in September 2025 as an Executive Assistant to Stacie Weninger, PhD and Chong Xu, PhD. Prior to joining F-Prime, she worked as an Administrative Assistant for Harvard Management Company, where she supported the finance, operations, and investment teams.
Tomesha earned her BA from Albright College and holds a dual MA from The Heller School at Brandeis University.
Tenzin Jampa joined F-Prime in 2025 as a data scientist, where he focuses on data science and automation. Tenzin graduated from MIT in 2025. During his time at MIT, he conducted research at the Laboratory for Nuclear Science, worked on analysing the early data samples from the 2024 LHCb Run, and evaluated Large Language Models for physics domain specialisation. Tenzin enjoys writing and occasionally publishes on his blog. In his free time, he loves to watch or play soccer, go on walks, play video games, or read.
Tenzin holds a B.S. degree from MIT in Physics and Philosophy.
Eric joined F-Prime in 2021 as a Venture Partner focused on executive leadership and go-to-market functions in technology and cybersecurity companies. Eric has founded and helped lead organizations from startup to $100 million plus revenue, including RiskRecon (acquired by Mastercard), Trusteer (acquired by IBM), Imprivata (IPO), and Centra Software (IPO).
Eric earned his undergraduate degree from Wharton School of University of Pennsylvania and his MBA from MIT Sloan School of Management.
Dr. Namandjé N. Bumpus joined F-Prime in 2025, where she serves as a strategic advisor on regulatory science, regulatory affairs, and policy, bringing deep expertise from her previous roles as FDA Principal Deputy Commissioner and Chief Scientist. Before the FDA, Dr. Bumpus was the E.K. Marshall and Thomas H. Maren Professor and director of the Department of Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine, where her research advanced understanding of drug metabolism, mechanisms of drug-induced toxicity, pharmacogenetics, bioanalytical chemistry, infectious disease pharmacology, and single cell biology. She completed her postdoctoral fellowship at The Scripps Research Institute and holds a PhD in pharmacology from the University of Michigan and a bachelor’s degree in biology from Occidental College.
Dr. Bumpus is a past-president of the American Society for Pharmacology and Experimental Therapeutics, a fellow of the American Association for the Advancement of Science, and a member of the National Academy of Medicine.
Catherine Stehman-Breen is a Venture Partner at F-Prime based in the Cambridge office, focusing on new company creation. She has more than 30 years of medical and biopharmaceutical experience. Prior to joining F-Prime, Catherine was CEO of Chroma Medicine, a company developing a novel epigenetic editing therapeutics platform where she built the company from inception. Previously, she was Chief Research and Development Officer at Obsidian Therapeutics, a cell therapy company developing engineered tumor infiltrating lymphocyte therapies for patients with solid tumors. As Entrepreneur in Residence at Atlas Venture, she worked closely with start-ups across a range of technologies and previously served as Chief Medical Officer at Sarepta Therapeutics. In addition, Catherine held various leadership roles at Regeneron and Amgen.
Catherine earned her MD from the University of Chicago. She completed her residency and nephrology fellowship training at the University of Washington, where she also received an MS in epidemiology. Catherine served as a faculty member in the division of nephrology and remains an affiliate associate professor in the University of Washington School of Public Health, with more than 90 publications in medical journals.
Michelle is the Director of Compliance and Risk at F-Prime. Michelle has more than 15 years of compliance and legal experience—leading several enterprise-wide compliance programs, including political law. Most recently, Michelle supported Fidelity Digital Assets®, a subsidiary of Fidelity Investments dedicated to digital assets. Prior to joining Fidelity, Michelle practiced law focusing on areas such as commercial bankruptcy, estate planning, business formation, immigration, and family violence protective orders.
Michelle received her law degree from Texas Wesleyan University School of Law (now Texas A&M University School of Law), and holds a BBA in Finance, magna cum laude, and MBA from the University of Texas at Arlington.
Jingwei is a Senior Associate at F-Prime, where he focuses on early-stage investments in digital assets. Prior to F-Prime, he invested in fintech with a particular focus on capital markets and investment management platforms. He previously worked at BCG on strategy and digital transformation projects. He began his career at the Bank of England, conducting macroprudential analysis and working on new bank authorisations.
Jingwei holds an MSc in Finance from Imperial College London. His interest in crypto began in 2017, when he helped raise $20 million via an ICO for a blockchain-based digital bank.
Claire Knowlton joined F-Prime in 2025 as a Marketing Associate. Claire supports marketing initiatives through event planning and internal communications. Previously, she worked at an estate planning law firm, focusing on email and social media marketing.
Claire holds a BA in Marketing from Loyola University Chicago.
Abby Wagner joined F-Prime in September 2024, and currently holds a Senior Accountant role. She previously held an Assurance Senior position at Ernst & Young, LLP serving primarily private clients in the wealth and asset management industry.
Abby earned an MBA and BS in Accounting with a Minor in Finance from Auburn University.
Lucia is an Executive Assistant and the Office Manager of F-Prime’s San Francisco Office. Lucia supports a number of Principals across the firm’s San Francisco and Cambridge offices.
Prior to F-Prime, Lucia was Executive Assistant to the Dean of Harvard’s John A. Paulson School of Engineering and Applied Sciences. Lucia also previously held EA and Development Associate roles at a non-profit in the Boston area, after transitioning from roles in Music.
Lucia received her M.M. in Collaborative Piano from the New England Conservatory of Music, and B.A. in Piano Performance from University of California, Santa Cruz.